Early research (Phase 1)Study completedNCT02983006What this trial is testingStudy of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV MelanomaWho this might be right forMelanoma NYU Langone Health 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06118333What this trial is testingA Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)Who this might be right forNasopharyngeal Carcinoma Sichuan Baili Pharmaceutical Co., Ltd. 386
Large-scale testing (Phase 3)UnknownNCT03605706What this trial is testingA Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.Who this might be right forAdvanced Hepatocellular Carcinoma Jiangsu HengRui Medicine Co., Ltd. 396
Large-scale testing (Phase 3)Ended earlyNCT02967692What this trial is testingThe Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Looking for participantsNCT06840834What this trial is testingEvaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and ChemotherapyWho this might be right forPleural Mesotheliomas Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Study completedNCT03958097What this trial is testingNatural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer The First Hospital of Jilin University 20
Large-scale testing (Phase 3)UnknownNCT03668496What this trial is testingSHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLCWho this might be right forLung Cancer Squamous CellLung Cancer Stage IVPD-1 Antibody+1 more Jiangsu HengRui Medicine Co., Ltd. 390
Large-scale testing (Phase 3)Study completedNCT03134872What this trial is testingSHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCWho this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+6 more Jiangsu HengRui Medicine Co., Ltd. 419
Not applicableStudy completedNCT04627012What this trial is testingLenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaAnti-PD1 AntibodyLiver Diseases Sun Yat-sen University 600
Testing effectiveness (Phase 2)UnknownNCT05749575What this trial is testingChidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.Who this might be right forBreast Cancer Sun Yat-sen University 28
Not applicableStudy completedNCT05775705What this trial is testingL-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLHWho this might be right forPD-1 AntibodyHemophagocytic LymphohistiocytosisEpstein-Barr Virus+1 more Beijing Friendship Hospital 24
Testing effectiveness (Phase 2)UnknownNCT03030001What this trial is testingPD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced MalignanciesWho this might be right forSolid Tumor, AdultAdvanced Cancer Ningbo Cancer Hospital 40
Early research (Phase 1)Study completedNCT03474640What this trial is testingSafety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesWho this might be right forAdvanced Malignancies TopAlliance Biosciences 184
Testing effectiveness (Phase 2)Looking for participantsNCT06468280What this trial is testingSynergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric CancerWho this might be right forGastric CancerGastroEsophageal Cancer Shanghai Zhongshan Hospital 84
Testing effectiveness (Phase 2)Study completedNCT03058289What this trial is testingA Phase 1/2 Safety Study of Intratumorally Dosed INT230-6Who this might be right forBreast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more Intensity Therapeutics, Inc. 111
Large-scale testing (Phase 3)UnknownNCT04084626What this trial is testingPD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBVWho this might be right forEBV Infection Beijing Friendship Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT04902040What this trial is testingPlinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesWho this might be right forAdvanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT06492408What this trial is testingNeoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.Who this might be right forHepatic CancerSurgery Second Affiliated Hospital of Guangzhou Medical University 90
Testing effectiveness (Phase 2)Looking for participantsNCT07644897What this trial is testingThymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaWho this might be right forMelanomaImmune-related Adverse EventImmune Checkpoint Inhibitor Sun Yat-sen University 55
Testing effectiveness (Phase 2)UnknownNCT04133259What this trial is testingEvaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B PatientsWho this might be right forHepatitis B, Chronic Henlix, Inc 44